- Report
- December 2023
- 80 Pages
Vietnam
From €1413EUR$1,500USD£1,208GBP
- Report
- December 2023
- 80 Pages
Russia
From €1413EUR$1,500USD£1,208GBP
- Report
- December 2023
- 80 Pages
Japan
From €1413EUR$1,500USD£1,208GBP
- Report
- December 2023
- 80 Pages
Ireland
From €1413EUR$1,500USD£1,208GBP
- Report
- December 2023
- 80 Pages
Brazil
From €1413EUR$1,500USD£1,208GBP
- Report
- April 2025
- 50 Pages
Global
From €2496EUR$2,650USD£2,135GBP
- Report
- January 2025
- 132 Pages
Global
From €895EUR$950USD£765GBP
Artesunate is an antimalarial drug used to treat severe malaria. It is a semi-synthetic derivative of the naturally occurring sesquiterpene lactone artemisinin, which is extracted from the plant Artemisia annua. Artesunate is used in combination with other antimalarial drugs to treat severe malaria, as it is more effective than monotherapy. It is also used to treat uncomplicated malaria, as it is more effective than other antimalarial drugs. Artesunate is available in both oral and injectable forms, and is used in combination with other antimalarial drugs to treat severe malaria.
The artesunate market is a rapidly growing market, driven by the increasing prevalence of malaria and the need for effective treatments. The market is expected to grow at a steady rate in the coming years, as the demand for antimalarial drugs increases.
Some of the major companies in the artesunate market include Sanofi, GlaxoSmithKline, Novartis, Pfizer, Merck, and Cipla. Show Less Read more